Breakthrough status for BioMarin ratchets up haemophilia A competitionThe FDA has granted Breakthrough Therapy Designation to BioMarin’s gene therapy for haemophilia A, helping to intensify competition Share XBreakthrough status for BioMarin ratchets up haemophilia A competitionhttps://pharmaphorum.com/news/breakthrough-status-biomarin-ratchets-haemophilia-competition/
